Skip to content
Screener

MoonLake Immunotherapeutics MLTX Portugal — Long-Lived Assets

Other geography segments

Switzerland
$888K+64.7%
United Kingdom
$553K-64.0%

Similar metrics at other companies

Avery Dennison logo
AVYChina Including Hong Kong — Long-Lived Assets
$273M-5.2%
Palo Alto Networks, Inc. logo
PANWIsrael — Long-Lived Assets
$162.1M+14.9%
Fabrinet logo
FNOthers — Long-Lived Assets
$590K+38.8%
BellRing Brands logo
BRBREurope — Long-Lived Assets
$13.5M+66.7%
nCino, Inc. logo
NCNOOther — Long-Lived Assets
$1.53M-17.4%
AES logo
AESARGENTINA — Long-Lived Assets
$475M+8.7%

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.53B-54.2%
Enterprise value$1.34B-57.2%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 8:55 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001821586-26-000007
(in thousands) / CountryMarch 31, 2026December 31, 2025
Switzerland$888$322
United Kingdom553804
Portugal9481,017
Total$2,389$2,143

Item 1. Financial Statements (Unaudited)

FAQ

What is MoonLake Immunotherapeutics's portugal — long-lived assets?
MoonLake Immunotherapeutics (MLTX) reported portugal — long-lived assets of $948K in Q1 2026.
How has MoonLake Immunotherapeutics's portugal — long-lived assets changed year-over-year?
MoonLake Immunotherapeutics's portugal — long-lived assets decreased by 22.5% year-over-year, from $1.22M to $948K.
What does portugal — long-lived assets mean?
This metric measures the total book value of non-current, tangible, and intangible assets located within the specified geographic segment. It reflects the company's capital investment and long-term commitment to infrastructure or intellectual property development in that region. Tracking this value assists in assessing the geographic concentration of the company's asset base and its potential for future operational capacity.

Ask your AI about MoonLake Immunotherapeutics's portugal — long-lived assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude